Fosamax Litigation
Fosamax® (Alendronate Sodium) is a member of a class of drugs known as “bisphosphonates.” Manufactured by Merck & Co., Fosamax was approved by the U.S. Food and Drug Administration in 1995, and is commonly used to treat patients with osteoporosis and Paget’s disease. Fosamax and other bisphosphonates, including Aredia® and Zometa®, have been linked to [...]
